(Q40342715)

English

Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection

scientific article published on 21 November 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

0 references

8

object named as

Jing An

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Qun Zheng

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Dongying Fan

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Na Gao

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Hui Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Juan Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Ying Ming

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Jieqiong Li

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

21 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

763-771

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Perspectives for the treatment of infections with Flaviviridae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Progress in development of a live-attenuated, tetravalent dengue virus vaccine by the United States Army Medical Research and Materiel Command.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Dengue tetravalent DNA vaccine increases its immunogenicity in mice when mixed with a dengue type 2 subunit vaccine or an inactivated Japanese encephalitis vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Co-expression of Japanese encephalitis virus prM-E-NS1 antigen with granulocyte-macrophage colony-stimulating factor enhances humoral and anti-virus immunity after DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

DNA vaccine against the non-structural 1 protein (NS1) of dengue 2 virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Membrane association and secretion of the Japanese encephalitis virus NS1 protein from cells expressing NS1 cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Enhanced efficacy of DNA vaccination against Her-2/neu tumor antigen by genetic adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Construction of a full length infectious clone for dengue-1 virus Western Pacific,74 strain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Suppression of immune response and protective immunity to a Japanese encephalitis virus DNA vaccine by coadministration of an IL-12-expressing plasmid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Vaccine-induced enhancement of viral infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Virus-Specific Cytolytic Antibodies to Nonstructural Protein 1 of Japanese Encephalitis Virus Effect Reduction of Virus Output from Infected Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Evaluation of immunity and protective efficacy of a dengue-3 pre-membrane and envelope DNA vaccine in Aotus nancymae monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Recombinant plasmid expressing a truncated dengue-2 virus E protein without co-expression of prM protein induces partial protection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Strategies for treating autoimmunity: novel insights from experimental myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.014

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.11.014

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40342715&oldid=1895757116"